Stanley Iyadurai
Director Técnico/Científico/I+D en CATALYST PHARMACEUTICALS, INC. .
Cargos activos de Stanley Iyadurai
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CATALYST PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 20/08/2018 | - |
Historial de carrera de Stanley Iyadurai
Antiguos cargos conocidos de Stanley Iyadurai.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/07/2017 | 01/07/2018 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Formación de Stanley Iyadurai.
University of Minnesota | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Stanley Iyadurai
- Experiencia